Literature DB >> 24761174

Recurrent Pregnancy Loss and Traditional Chinese Medicine.

Lee Hullender Rubin1, Dara Cantor1, Benjamin L Marx1.   

Abstract

BACKGROUND: Recurrent pregnancy loss (RPL) can present with coexistent subfertility caused by diminished ovarian reserve (DOR). Recent texts suggest that Traditional Chinese Medicine (TCM) may improve pregnancy outcomes for women with RPL.
OBJECTIVE: This article reports the outcome of the treatment of a female of advanced maternal age. She had diagnoses of DOR and RPL. DESIGN SETTING AND PATIENT: This 42-year-old patient with DOR and RPL presented in a private acupuncture practice, located in Bellevue, WA. INTERVENTION: The patient received TCM treatment that involved weekly acupuncture and Chinese herbal therapy from June 2006 to May 2007. MAIN OUTCOME MEASURES: The outcome sought was a live birth after 24 weeks of gestation.
RESULTS: After another miscarriage in September 2006, this patient conceived a viable pregnancy in December 2006, after 6 months of treatment. She continued treatment through 20 weeks and delivered a healthy son at 39.5 weeks of gestation.
CONCLUSIONS: Subfertile women with RPL may benefit from TCM treatment. More research is needed to examine the safety and effectiveness of TCM as a treatment for RPL.

Entities:  

Keywords:  Acupuncture; Infertility; Spontaneous Abortion; Traditional Chinese Medicine

Year:  2013        PMID: 24761174      PMCID: PMC3689170          DOI: 10.1089/acu.2012.0911

Source DB:  PubMed          Journal:  Med Acupunct        ISSN: 1933-6586


  7 in total

1.  Acupuncture needle sensations associated with De Qi: a classification based on experts' ratings.

Authors:  Hugh MacPherson; Aziz Asghar
Journal:  J Altern Complement Med       Date:  2006-09       Impact factor: 2.579

Review 2.  Spontaneous abortion.

Authors:  W Z McBride
Journal:  Am Fam Physician       Date:  1991-01       Impact factor: 3.292

3.  Implications of sperm chromosome abnormalities in recurrent miscarriage.

Authors:  C Rubio; C Simón; J Blanco; F Vidal; Y Mínguez; J Egozcue; J Crespo; J Remohí; A Pellicer
Journal:  J Assist Reprod Genet       Date:  1999-05       Impact factor: 3.412

Review 4.  Evidence-based investigations and treatments of recurrent pregnancy loss.

Authors:  Ole B Christiansen; Anne-Marie Nybo Andersen; Ernesto Bosch; Salim Daya; Peter J Delves; Thomas V Hviid; William H Kutteh; Susan M Laird; Tin-Chiu Li; Katrin van der Ven
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

5.  Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study.

Authors:  Elise de la Rochebrochard; Patrick Thonneau
Journal:  Hum Reprod       Date:  2002-06       Impact factor: 6.918

6.  Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss.

Authors:  D T Carrell; L Liu; C M Peterson; K P Jones; H H Hatasaka; L Erickson; B Campbell
Journal:  Arch Androl       Date:  2003 Jan-Feb

7.  Changes in serum cortisol and prolactin associated with acupuncture during controlled ovarian hyperstimulation in women undergoing in vitro fertilization-embryo transfer treatment.

Authors:  Paul C Magarelli; Diane K Cridennda; Mel Cohen
Journal:  Fertil Steril       Date:  2008-12-31       Impact factor: 7.329

  7 in total
  3 in total

1.  Impact of whole systems traditional Chinese medicine on in-vitro fertilization outcomes.

Authors:  Lee E Hullender Rubin; Michael S Opsahl; Klaus E Wiemer; Scott D Mist; Aaron B Caughey
Journal:  Reprod Biomed Online       Date:  2015-02-24       Impact factor: 3.828

2.  The Role of Dendritic Cell Subsets in Recurrent Spontaneous Abortion and the Regulatory Effect of Baicalin on It.

Authors:  Nannan Lai; Xiaoxiao Fu; Guozhen Hei; Weiwei Song; Ran Wei; Xiaoxiao Zhu; Qiang Guo; Zhen Zhang; Chu Chu; Ke Xu; Xia Li
Journal:  J Immunol Res       Date:  2022-02-17       Impact factor: 4.818

3.  Psoralen Promotes Proliferation, Migration, and Invasion of Human Extravillous Trophoblast Derived HTR-8/Svneo Cells in vitro by NF-κB Pathway.

Authors:  Dan Qi; Jingyuan Lu; Ziyi Fu; Shanshan Lv; Lili Hou
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.